Literature DB >> 11788650

LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects.

Michelangela Barbieri1, Massimiliano Bonafè, Raffaele Marfella, Emilia Ragno, Dario Giugliano, Claudio Franceschi, Giuseppe Paolisso.   

Abstract

The LL genotype among subjects with paraoxonase (PON) polymorphism Met-Leu 54 has been shown to be associated with elevated risk of coronary heart disease. Indeed, insulin resistance (IR) is a well known cardiovascular risk factor that is likely attributable to a genetic background, lifestyle, and environmental factors such oxidative stress. Because subjects sharing the LL genotype have a more elevated degree of oxidative stress, one cannot rule out that in those subjects a more severe degree of IR can occur. Thus, the possible relationship between PON gene polymorphism and degree of IR was investigated. In 213 healthy subjects, the degree of IR was assessed by the homeostasis model assessment, and the Met-Leu 54 PON polymorphism was detected. The frequency was 0.366 for the LL genotype, 0.469 for the LM genotype, and 0.164 for the MM genotype. Comparing the three genotype groups, LL genotype had the more severe degree of IR, compared with LM (P < 0.01) and MM (P < 0.01) genotypes. No difference between LM and MM genotypes was found (P = 0.49). Subjects carrying the LL genotype were associated with the IR syndrome picture more than individuals carrying the M allele because they were more overweight and had the highest levels of triglycerides and blood pressure and the lowest values of plasma high-density lipoprotein cholesterol. In a multivariate stepwise regression analysis, LL genotype was a significant predictor of IR, independent of age, sex, body mass index, fasting plasma triglycerides, and high-density lipoprotein cholesterol (P < 0.001). In conclusion, the presence of LL PON genotype is associated with a more severe degree of IR. Thus, IR might be the possible missing link between Met-Leu 54 PON polymorphism and the increased cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788650     DOI: 10.1210/jcem.87.1.8183

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1.

Authors:  M C Blatter-Garin; B Kalix; S De Pree; R W James
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

2.  The hOGG1 Ser326Cys gene polymorphism is associated with decreased insulin sensitivity in subjects with normal glucose tolerance.

Authors:  Chiao-Ling Wang; Ming-Chia Hsieh; Shih-Chieh Hsin; Hsing-Yi Lin; Kun-Der Lin; Chao-Sheng Lo; Zhao-Hong Chen; Shyi-Jang Shin
Journal:  J Hum Genet       Date:  2005-12-07       Impact factor: 3.172

Review 3.  Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.

Authors:  Boris Hansel; Anatol Kontush; Dominique Bonnefont-Rousselot; Eric Bruckert; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

Review 4.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 5.  Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.

Authors:  Md Rafiqul Islam; Dale R Nyholt
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

Review 6.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

7.  Paraoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin.

Authors:  Francesca Marchegiani; Liana Spazzafumo; Maurizio Cardelli; Mauro Provinciali; Francesco Lescai; Claudio Franceschi; Roberto Antonicelli
Journal:  J Lipids       Date:  2012-03-25

8.  Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus.

Authors:  Dalia El-Lebedy; Mona Kafoury; Dalia Abd-El Haleem; Alshaymaa Ibrahim; Eman Awadallah; Ingy Ashmawy
Journal:  J Diabetes Metab Disord       Date:  2014-12-20

9.  Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.

Authors:  Abdelghani Bounafaa; Hicham Berrougui; Noreddine Ghalim; Boubker Nasser; Abdallah Bagri; Abderrahmane Moujahid; Souad Ikhlef; Pamela Camponova; Najoua Yamoul; Olivier Kamtchueng Simo; Abdelkhalid Essamadi; Abdelouahed Khalil
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

10.  Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes.

Authors:  Durdi Qujeq; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi; Saleh Annemohammadzadeh; Ruzbeh Boorank
Journal:  J Diabetes Metab Disord       Date:  2018-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.